Skip to main content

Table 4 Clinical data in 145 patients who developed thrombocytopenia

From: Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome

Variable

Value

Development of thrombocytopenia

 

  At the time of ICU admit, n (%)

77 (25.3)

  During the ICU/hospital course, n (%)

68 (22.3)

Duration of thrombocytopenia (days), median (IQR)

4.4 (1.9–6.9)

Resolution of thrombocytopenia by hospital discharge, n (%)

86 (59.3)

Severity of thrombocytopenia

 

  Mild, n (%)

72 (49.6)

  Moderate, n (%)

47 (32.4)

  Severe, n (%)

19 (13.1)

  Very severe, n (%)

7 (4.8)

Disseminated intravascular coagulation, n (%)

37 (25.5)

Drug-induced thrombocytopenia, n (%)

26 (17.9)

Heparin-induced thrombocytopenia, n (%)

1 (0.6)

  1. ICU, intensive care unit; IQR, interquartile range.